Vanadium in diabetes: 100 years from Phase 0 to Phase I

Journal of Inorganic Biochemistry

Volumn 100, Issue 12, 2006, Pages 1925-1935

  Thompson, Katherine H ^a   Orvig, Chris ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biodistribution; Bis(ethylmaltolato)oxovanadium(IV); Diabetes mellitus; Vanadium

Indexed keywords

1,10 PHENANTHROLINE; 5 [4 (5 HYDROXY 4 OXO 4H PYRAN 2 YLMETHOXY)BENZYL]THIAZOLIDINE 2,4 DIONE; 5 [4 (5 HYDROXY 4 OXO 4H PYRAN 2 YLMETHOXY)BENZYLIDENE]THIAZOLIDINE 2,4 DIONE; 5 [4 [(5 HYDROXY 4 OXO 4H PYRAN 2 YLMETHYL)AMINO]BENZYL]THIAZOLIDINE 2,4 DIONE; 6 METHYLPICOLINIC ACID; ALLIXIN; AMMONIUM VANADATE; BIS(ALLIXINATO)OXOVANADIUM; BIS(ETHYLMALTOLATO)OXOVANADIUM; BIS(MALTOLATO)OXOVANADIUM; ETHYLMALTOL; HUMAN SERUM ALBUMIN; HYDROXAMIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; IODOPICOLINIC ACID; MALTOL; METFORMIN; PEROXOVANADIUM; PICOLINATO VANADYL COMPLEX; PICOLINIC ACID; TIRON; UNCLASSIFIED DRUG; VANADATE SODIUM; VANADIUM ACETATE; VANADIUM DERIVATIVE; VANADYL SULFATE; VANADYLACETYLACETONATE; VANADYLCURCUMIN; VANADYLMETFORMIN; VANADYLTHIAZOLIDINEDIONE DERIVATIVE;

ACUTE TOXICITY; CLINICAL TRIAL; DIABETES MELLITUS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG OXIDATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TRANSFORMATION; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN SENSITIVITY; IONTOPHORESIS; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; TREATMENT OUTCOME;

BLOOD GLUCOSE; CLINICAL TRIALS, PHASE I; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; VANADIUM COMPOUNDS;

EID: 33750955253     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2006.08.016     Document Type: Review

References (193)

1. Lyonnet B.M., and Martz Martin E. La Presse Med. 7 (1899) 191-192
2. Laran M. La Presse Med. 7 (1899) 190-191
3. Orvig C., Thompson K.H., Liboiron B.D., McNeill J.H., and Yuen V.G. J. Inorg. Biochem. 96 (2003) 14 (Abstr.) (Presented by C. Orvig at ICBIC 11, Cairns, QLD, Australia, 2003.)
4. Thompson K.H., and Orvig C. Dalton Trans. (2006) 761-764
5. http://www.biochem-fitness.com, 2002.
6. AdvancedHealthServices.net, http://www.sportsnstuff.com/health, 2006.
7. Nutraceutical Research, http://www.emersonecologics.com, 2006.
8. Rehder D. Inorg. Chem. Commun. 6 (2003) 604-617
9. Thompson K.H., McNeill J.H., and Orvig C. Chem. Rev. 99 (1999) 2561-2571
10. Thompson K.H., and Orvig C. Met. Ions Biol. Syst. 41 (2004) 221-252
11. Sakurai H., Tamura A., Fugono J., Yasui H., and Kiss T. Coord. Chem. Rev. 245 (2003) 31-37
12. Crans D.C., Smee J.J., Gaidamauskas E., and Yang L. Chem. Rev. 104 (2004) 849-902
13. Srivastava A.K., and Mehdi M.Z. Diabetic Med. 22 (2004) 2-13
14. Thompson K.H., Liboiron B.D., Hanson G.R., and Orvig C. In vivo coordination chemistry and biolocalization of bis(ligand)oxovanadium(IV) complexes for diabetes treatment. In: Sessler J.L., Doctrow S.R., McMurry T.J., and Lippard S.J. (Eds). Medicinal Inorganic Chemistry. ACS Symposium Series vol. 903 (2005), American Chemical Society, Washington, DC 384-399
15. Banting F.G., Best C.H., Collip J.B., Campbell W.R., and Fletcher A.A. Can. Med. Assoc. J. 12 (1922) 141
16. Schroeder H.A., Balassa J.J., and Tipton I.H. J. Chron. Dis. 16 (1963) 1047-1071
17. Bernheim F., and Bernheim M.L.C. J. Biol. Chem. 127 (1939) 353-360
18. Mountain J.T., Delker L.L., and Stokinger H.E. Arch. Ind. Hyg. 8 (1953) 406-411
19. Curran G.L. J. Biol. Chem. 210 (1954) 765-770
20. Talvitie N.A., and Wagner W.D. Ind. Hyg. Occup. Med. 9 (1954) 414-424
21. Curran G.L., Azarnoff D.L., and Bolinger R.E. J. Clin. Invest. 38 (1959) 1251-1261
22. Somerville J., and Davies B. Am. Heart J. 64 (1962) 54-56
23. Dimond E.G., Caravaca J., and Benchimol A. Am. J. Clin. Nutr. 12 (1963) 49-53
24. Dodge R.R., Templeton D., and Zalkin A. J. Chem. Phys. 35 (1961) 55-67
25. Carrington A., and Symons M.C.R. Chem. Rev. 63 (1963) 443-460
26. Dutta R.L., and Lahiry S. J. Ind. Chem. Soc. 40 (1963) 67-73
27. Dutta R.L., and Lahiry S. J. Ind. Chem. Soc. 40 (1963) 53-66
28. Dutta R.L., and Lahiry S. J. Ind. Chem. Soc. 39 (1962) 860-870
29. Dutta R.L., and Lahiry S. J. Ind. Chem. Soc. 41 (1964) 546-548
30. Kivelson D., and Lee S.L. J. Chem. Phys. 41 (1964) 1896-1903
31. Selbin J. Chem. Rev. 65 (1965) 153-175
32. Pope M.T., and Dale B.W. Q. Rev. Chem. Soc. 22 (1968) 527-548
33. Hopkins Jr. L.L., and Tilton B.E. Am. J. Physiol. 211 (1966) 169-172
34. Hopkins Jr. L.L., and Mohr H.E. Fed. Proc. 33 (1974) 1773-1775
35. Schwarz K., and Milne D.B. Science 174 (1971) 426-428
36. Beauge L.A., and Glynn I.M. Nature 268 (1977) 355-356
37. Cantley Jr. L.C., Josephson L., Warner R., Yanagisawa M., Lechene C., and Guidotti G. J. Biol. Chem. 252 (1977) 7421-7423
38. Josephson L., and Cantley Jr. L.C. Biochemistry 16 (1977) 4572-4578
39. Beauge L.A., and Glynn I.M. Nature 272 (1978) 551-552
40. Cantley Jr. L.C., Resh M.D., and Guidotti G. Nature 272 (1978) 552-554
41. Karlish S.J.D., Beauge L.A., and Glynn I.M. Nature 282 (1979) 333-335
42. Gordon J.A. Meth. Enzymol. 201 (1991) 477-482
43. Cantley Jr. L.C., and Aisen P. J. Biol. Chem. 254 (1979) 1781-1784
44. Boyd D.W., and Kustin K. Adv. Inorg. Biochem. 6 (1984) 311-363
45. Erdmann E., Werdan K., Krawietz W., Schmitz W., and Scholz H. Biochem. Pharmacol. 33 (1984) 945-950
46. Macara I.G. Trends Biochem. Sci. 5 (1980) 92-94
47. Erdmann E. Basic Res. Cardiol. 75 (1980) 411-412
48. Tolman E.L., Barris E., Burns M., Pansisni A., and Partridge R. Life Sci. 25 (1979) 1159-1164
49. Dubyak G.R., and Kleinzeller A. J. Biol. Chem. 255 (1980) 5306-5312
50. Shechter Y., and Karlish S.J.D. Nature (London) 284 (1980) 556-558
51. Clausen T., Andersen T.L., Sturup-Johansen M., and Petkova O. Biochim. Biophys. Acta 646 (1981) 261-267
52. Kustin K., and Macara I.G. Comm. Inorg. Chem. 2 (1982) 1-22
53. Shechter Y., Meyerovitch J., Farfel Z., Sack J., Bruck R., Bar-Meir S., Amir S., Degani H., and Karlish S.J.D. In: Chasteen N.D. (Ed). Vanadium in Biological Systems (1990), Kluwer, Dordrecht 129-142
54. Ramasarma T., and Crane F.L. Curr. Top. Cell. Reg. 20 (1981) 247-301
55. Degani H., Gochin M., Karlish S.J.D., and Shechter Y. Biochemistry 20 (1981) 5795-5799
56. Rubinson K.A. Proc. R. Soc. Lond., Ser. B 212 (1981) 65-84
57. Sakurai H., Shimomura S., and Ishizu K. Inorg. Chim. Acta 55 (1981) L67-L69
58. Nechay B.R. Ann. Rev. Pharmacol. Toxicol. 24 (1984) 501-524
59. Harris W.R., Friedman S.R., and Silberman D. J. Inorg. Biochem. 20 (1984) 157-169
60. Chasteen N.D. Struct. Bond. (Berlin) 53 (1983) 105-138
61. Willsky G.R., White D.A., and McCabe B.C. J. Biol. Chem. 259 (1984) 13273-13281
62. Bell R.H.J., and Hye R.J. J. Surg. Res. 35 (1983) 433-460
63. Heyliger C.E., Tahiliani A.G., and McNeill J.H. Science 227 (1985) 1474-1477
64. Byrne A.R., and Kosta L. Sci. Total Environ. 10 (1978) 17-30
65. Cornelis R., Versieck J., Mees L., Hoste J., and Barbier F. Biol. Trace Elem. Res. 3 (1981) 257-263
66. Stroop S.D., Helinek G., and Greene H.L. Clin. Chem. 28 (1982) 79-82
67. Challiss R.A.J., Leighton B., Lozeman F.J., Budohoski L., and Newsholme E.A. Biochem. Pharmacol. 36 (1987) 357-361
68. Meyerovitch J., Farfel Z., Sack J., and Shechter Y. J. Biol. Chem. 262 (1987) 6658-6662
69. Brichard S.M., Okitolonda W., and Henquin J.C. Endocrinology 123 (1988) 2048-2053
70. Gil J., Miralpeix M., Carreras J., and Bartrons R. J. Biol. Chem. 263 (1988) 1868-1871
71. Rossetti L., and Laughlin M.R. J. Clin. Invest. 84 (1989) 892-899
72. Sakurai H., Tsuchiya K., Nukatsuka M., Sofue M., and Kawada J. J. Endocrinol. 126 (1990) 451-459
73. In: Chasteen N.D. (Ed). Vanadium in Biological Systems (1990), Kluwer, Dordrecht
74. Posner B.I., Shaver A., and Fantus I.G. Insulin mimetic agents: vanadium and peroxovanadium compounds. In: Bailey C.J., and Flatt P.R. (Eds). New Antidiabetic Drugs (1990), Smith Gordon, London 107-118
75. Ramanadham S., Brownsey R.W., Cros G.H., Mongold J.J., and McNeill J.H. Metabolism 38 (1989) 1022-1028
76. Ramanadham S., Mongold J.J., Brownsey R.W., Cros G.H., and McNeill J.H. Am. J. Physiol. 257 (1989) H904-H911
77. Mongold J.J., Cros G.H., Vian L., Tep A., Ramanadham S., Siou G., Diaz J., McNeill J.H., and Serrano J.J. Pharmacol. Toxicol. 67 (1990) 192-198
78. Bendayan M., and Gingras D. Diabetologia 32 (1989) 561-567
79. Brichard S.M., Pottier A.M., and Henquin J.C. Endocrinology 125 (1989) 2510-2516
80. Pederson R.A., Ramanadham S., Buchan A.M.J., and McNeill J.H. Diabetes 38 (1989) 1390-1395
81. Brichard S.M., Bailey C.J., and Henquin J.-C. Diabetes 39 (1990) 1326-1332
82. Thompson K.H., Leichter J., and McNeill J.H. Biochem. Biophys. Res. Commun. 197 (1993) 1549-1555
83. Marliss E.B. Metabolism 32 Suppl. 1 (1983) 1-3
84. Thompson K.H., and McNeill J.H. Res. Comm. Chem. Pathol. Pharmacol. 80 (1993) 187-200
85. Dai S., Thompson K.H., and McNeill J.H. Pharmacol. Toxicol. 74 (1994) 101-109
86. Orvig C., Thompson K.H., Battell M., and McNeill J.H. Met. Ions Biol. Syst. 31 (1995) 575-594
87. Llobet J.M., and Domingo J.L. Toxicol. Lett. 23 (1984) 227-231
88. Venugopal B.L., and Luckey T.D. Chemical Toxicity of Metals and Metalloids vol. 2 (1978), Plenum Press, New York
89. Chasteen N.D., Lord E.M., and Thompson H.J. Vanadium metabolism. Vanadyl(IV) electron paramagnetic resonance spectroscopy of selected tissues in the rat. In: Xavier A. (Ed). Frontiers in Bioinorganic Chemistry (1985), VCH Publishers, Weinheim 133-141
90. Nechay B.R., Nanninga L.B., Nechay P.S.E., Post R.L., Grantham J.J., Macara I.G., Kubena L.F., Phillips T.D., and Nielsen F.H. Fed. Proc. 45 (1986) 123-132
91. Sabbioni E., and Marafante E. Bioinorg. Chem. 9 (1978) 389-407
92. Parker R.D.R., and Sharma R.P. J. Environ. Pathol. Toxicol. 2 (1978) 235-245
93. Nielsen F.H. Possible future implications of nickel, arsenic, silicon, vanadium, and other trace elements in human nutrition. In: Prasad A.S. (Ed). Clinical, Biochemical, and Nutritional Aspects of Trace Elements (1982), A.R. Liss, New York 379-404
94. Sabbioni E., Marafante E., Amantini L., Ubertalli L., and Birattari C. Bioinorg. Chem. 8 (1978) 503-515
95. Harris W.R., and Carrano C.J. J. Inorg. Biochem. 22 (1984) 201-218
96. Chasteen N.D., Grady J.K., and Holloway C.E. Inorg. Chem. 25 (1986) 2754-2760
97. Patterson B.W., Hansard II S.L., Ammerman C.B., Henry P.R., Zech L.A., and Fisher W.R. Am. J. Physiol. 251 (1986) R325-R332
98. Bogden J.D., Higashino H., Lavenhar M.A., Bauman Jr. J.W., Kemp F.W., and Aviv A. J. Nutr. 112 (1982) 2279-2285
99. McNeill J.H., Yuen V.G., Hoveyda H.R., and Orvig C. J. Med. Chem. 35 (1992) 1489-1491
100. Caravan P., Gelmini L., Glover N., Herring F.G., Li H., McNeill J.H., Rettig S.J., Setyawati I.A., Shuter E., Sun Y., Tracey A.S., Yuen V.G., and Orvig C. J. Am. Chem. Soc. 117 (1995) 12759-12770
101. Yuen V.G., Orvig C., and McNeill J.H. Can. J. Physiol. Pharmacol. 73 (1995) 55-64
102. Thompson K.H., Yuen V.G., McNeill J.H., and Orvig C. Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes. In: Tracey A.S., and Crans D.C. (Eds). Vanadium Compounds. Chemistry, Biochemistry, and Therapeutic Applications. ACS Symposium Series vol. 711 (1998), American Chemical Society, Washington, DC 329-343
103. Sakurai H., Tsuchiya K., Nukatsuka M., Kawada J., Ishikawa S., Yoshida H., and Komatsu M. J. Clin. Biochem. Nutr. 8 (1990) 193-200
104. Setyawati I.A., Thompson K.H., Sun Y., Lyster D.M., Vo C., Yuen V.G., Battell M., McNeill J.H., Ruth T.J., Zeisler S., and Orvig C. J. Appl. Physiol. 84 (1998) 569-575
105. Thompson K.H., Barta C.A., and Orvig C. Chem. Soc. Rev. 35 (2006) 545-556
106. Shechter Y., Shisheva A., Lazar R., Libman J., and Shanzer A. Biochemistry 31 (1992) 2063-2068
107. Watanabe H., Nakai M., Komazawa K., and Sakurai H. J. Med. Chem. 37 (1994) 876-877
108. Fujimoto S., Fujii K., Yasui H., Matsushita R., Takada J., and Sakurai H. J. Clin. Biochem. Nutr. 23 (1997) 113-129
109. Thompson K.H., Liboiron B.D., Sun Y., Bellman K.D.D., Setyawati I.A., Patrick B.O., Karunaratne V., Rawji G., Wheeler J., Sutton K., Bhanot S., Cassidy C., McNeill J.H., Yuen V.G., and Orvig C. J. Biol. Inorg. Chem. 8 (2003) 66-74
110. Melchior M., Rettig S.J., Liboiron B.D., Thompson K.H., Yuen V.G., McNeill J.H., and Orvig C. Inorg. Chem. 40 (2001) 4686-4690
111. Crans D.C., Yang L., Jakusch T., and Kiss T. Inorg. Chem. 39 (2000) 4409-4416
112. Kadota S., Fantus G., Deragon G., Guyda H.J., Hersh B., and Posner B.I. Biochem. Biophys. Res. Commun. 147 (1987) 259-266
113. Fantus I.G., Kadota S., Deragon G., Foster B., and Posner B.I. Biochemistry 28 (1989) 8864-8871
114. Posner B.I., Faure R., Burgess J.W., Bevan A.P., Lachance D., Zhang-Sun G., Fantus I.G., Ng J.B., Hall D.A., Soo Lum B., and Shaver A. J. Biol. Chem. 269 (1994) 4460-4596
115. Crans D.C., Keramida A.D., Hoover-Litty H., Anderson O.P., Miller M.M., Lemoine L.M., Pleasic-Williams S., Vandenberg M., Rossomoando A.J., and Sweet L.J. J. Am. Chem. Soc. 119 (1997) 5447-5448
116. Morinville A., Maysinger D., and Shaver A. Trends Pharm. Sci. 19 (1998) 452-460
117. Goldfine A.B., Simonson D.C., Folli F., Patti M.-E., and Kahn C.R. J. Clin. Endocrinol. Metab. 80 (1995) 3311-3320
118. Halberstam M., Cohen N., Shlimovich P., Chang C.J., Shamoon H., and Rossetti L. Diabetes 45 (1996) 659-666
119. Goldfine A.B., Willsky G.R., and Kahn C.R. Vanadium salts in the treatment of human diabetes mellitus. In: Tracey A.S., and Crans D.C. (Eds). Vanadium compounds. Chemistry, Biochemistry, and Therapeutic Applications. ACS Symposium Series vol. 711 (1998), American Chemical Society, Washington, DC 353-368
120. Cohen N., Halberstam M., Shlimovich P., Chang C.J., Shamoon H., and Rossetti L. J. Clin. Invest. 95 (1995) 2501-2509
121. G.R. Willsky, A.B. Goldfine, P.J. Kostyniak, Pharmacology and toxicology of oxovanaidum species: oxovanadium pharmacology, in: A.S. Tracey, D.C. Crans (Eds.), Vanadium Compounds: Chemistry, Biochemistry and Therapeutic Applications, ACS Symposium Series, vol. 711, Washington, DC, 1998, pp. 278-296.
122. Cusi K., cukier S., DeFronzo R.A., Torres M., Puchulu F.M., and Pereira Redondo J.C. J. Clin. Endocrinol. Metab. 86 (2001) 1410-1417
123. Cam M.C., Pederson R.A., Brownsey R.W., and McNeill J.H. Diabetologia 36 (1993) 218-224
124. Thompson K.H., Tsukada Y., Xu Z., Battell M., McNeill J.H., and Orvig C. Biol. Trace Elem. Res. 86 (2002) 31-44
125. Crans D.C., Mahroof-Tahir M., and Keramidas A.D. Mol. Cell. Biochem. 153 (1995) 17-24
126. Brichard S.M., Lederer J., and Henquin J.-C. Diab. Metab. (Paris) 17 (1991) 435-440
127. Shisheva A., and Shechter Y. Biochemistry 31 (1992) 8059-8063
128. Shechter Y., and Shisheva A. Endeavour, New Series 17 (1993) 27-31
129. Pugazhenthi S., Angel J.F., and Khandelwal R.L. Mol. Cell. Biochem. 122 (1993) 77-84
130. Tsukamoto Y., Saka S., Kumano K., Iwanami S., Ishida O., and Marumo F. Nephron 56 (1990) 368-373
131. Bruech M., Quintanilla M.E., Legrum W., Koch J., Netter K.J., and Fuhrmann G.F. Toxicology 31 (1984) 283-295
132. Shechter Y., Meyerovitch J., Gefel D., Bruck R., Shisheva A., Elberg G., Libman J., and Shanzer A. Front. Endocrinol. 1 (1993) 51-63
133. Srivastava P., Saxena A.K., Kale R.K., and Baquer N.Z. Res. Commun. Chem. Path. Pharmacol. 80 (1993) 283-293
134. Yuen V.G., Orvig C., and McNeill J.H. Can. J. Physiol. Pharmacol. 71 (1993) 263-269
135. Becker D.J., Ongemba L.-N., and Henquin J.-C. Eur. J. Pharmacol. 260 (1994) 169-175
136. Brichard S.M., and Henquin J.-C. Trends Pharmacol. Sci. 16 (1995) 265-270
137. J.H. McNeill, H.R. Hoveyda, C. Orvig, 1994, Complexed vanadium for treatment of diabetes mellitus, U.S. Patent No. 5,300,496.
138. J.H. McNeill, C. Orvig, 1996, Bis(maltolato)oxovanadium Compositions for the Treatment of Elevated Blood Sugar, U.S. Patent No. 5,527,790.
139. Al-Bayati M., Raabe O.G., Giri S.N., and Knaak J.B. J. Am. Coll. Toxicol. 10 (1991) 233-241
140. Conklin A.W., Skinner C.S., Felten T.L., and Sanders C.L. Toxicol. Lett. 11 (1982) 199-203
141. Wiegmann T.B., Day H.D., and Patak R.V. J. Toxicol. Environ. Health 10 (1982) 233-245
142. Yasui H., Takechi K., and Sakurai H. J. Inorg. Biochem. 78 (2000) 185-196
143. Takino T., Yasui H., Yoshitake A., Hamajima Y., Matsushita R., Takada J., and Sakurai H. J. Biol. Inorg. Chem. 6 (2001) 133-142
144. Orvig C., and Abrams M.J. Chem. Rev. 99 (1999) 2201-2203
145. Song B., Aebischer N., and Orvig C. Inorg. Chem. 41 (2002) 1357-1364
146. Kiss T., Kiss E., Garribba E., and Sakurai H. J. Inorg. Biochem. 80 (2000) 65-73
147. Kiss E., Fabian I., and Kiss T. Inorg. Chim. Acta 340 (2002) 114-118
148. Kiss E., Kawabe K., Tamura A., Jakusch T., Sakurai H., and Kiss T. J. Inorg. Biochem. 95 (2003) 69-76
149. Liboiron B.D., Thompson K.H., Hanson G.R., Lam E., Aebischer N., and Orvig C. J. Am. Chem. Soc. 127 (2004) 5104-5115
150. da Silva Santos J.M., Carvalho S., Paniago E.B., and Duarte H.A. J. Inorg. Biochem. 95 (2003) 14-24
151. Liboiron B.D., Thompson K.H., Hanson G.R., Lam E., Aebischer N., and Orvig C. J. Am. Chem. Soc. 127 (2004) 5104-5115
152. Yasui H., Tamura A., Takino T., and Sakurai H. J. Inorg. Biochem. 91 (2002) 327-338
153. Ou H., Yan L., Mustafi D., Makinen M.W., and Brady M.J. J. Biol. Inorg. Chem. 10 (2005) 874-886
154. Zhang S.-Q., Ahong X.-Y., Lu W.-L., Zhen L., Zhang X., Sun F., Fu G.-Y., and Zhang Q. J. Inorg. Biochem. 99 (2005) 1064-1075
155. Thompson K.H., and Orvig C. Science 300 (2003) 936-939
156. Chasteen N.D., and Francavilla J. J. Phys. Chem. 80 (1976) 867-871
157. Chasteen N.D., Lord E.M., Thompson H.J., and Grady J.K. Biochim. Biophys. Acta 884 (1986) 84-92
158. Yasui H., Kunori Y., and Sakurai H. Chem. Lett. 32 (2003) 1032-1033
159. Nechay B.R., Nanninga L.B., and Nechay P.S.E. Arch. Biochem. Biophys. 251 (1986) 128-138
160. Tracey A.S., Gresser M.J., and Parkinson K.M. Inorg. Chem. (1987) 629-638
161. Buglyó P., Kiss T., Kiss E., Sanna D., Garribba E., and Micera G. J. Chem. Soc., Dalton Trans. 2002 (2002) 2275-2282
162. Tsiani E., and Fantus I.G. Trends Endocrinol. Metab. 8 (1997) 51-58
163. Goldwaser I., Qian S., Gershonov E., Fridkin M., and Shechter Y. Mol. Pharmacol. 58 (2000) 738-746
164. Monga V., Thompson K.H., Yuen V.G., Sharma V., Patrick B.O., McNeill J.H., and Orvig C. Inorg. Chem. 44 (2004) 2678-2688
165. Reul B.A., Amin S.S., Buchet J.-P., Ongemba L.N., Crans D.C., and Brichard S.M. Br. J. Pharmacol. 126 (1999) 467-477
166. Amin S.S., Cryer K., Zhang B., Dutta S.K., Eaton S.S., Anderson O.P., Miller S.M., Reul B.A., Brichard S.M., and Crans D.C. Inorg. Chem. 39 (2000) 406-416
167. Straganz G.D., Glieder A., Brecker L., Ribbons D.W., and Steiner W. Biochem. J. 369 (2003) 573-581
168. Beskid M., Jachimowicz J., Taraszewska A., and Kukulska D. Exp. Toxicol. Pathol. 47 (1995) 25-30
169. Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., Tsaprailis G., Gresser M.J., and Ramachandran C. J. Biol. Chem. 272 (1997) 843-851
170. Shechter Y., Li J., Meyerovitch J., Gefel D., Bruck R., Elberg G., Miller D.S., and Shisheva A. Mol. Cell. Biochem. 153 (1995) 39-47
171. Elberg G., He Z., Li J., Sekar N., and Shecther Y. Diabetes 46 (1997) 1684-1690
172. Li J., Elberg G., Sekar N., He Z.B., and Shechter Y. Endocrinology 138 (1997) 2274-2279
173. Shafrir E., Speilman S., Nachliel I., Khamaisi M., Bar-On H., and Ziv E. Diabetes Metab. Res. Rev. 17 (2001) 55-66
174. Sekar N., Li J., and Shechter Y. Crit. Rev. Biochem. Mol. Biol. 31 (1996) 339-359
175. Fantus I.G., and Tsiani E. Mol. Cell. Biochem. 182 (1998) 109-119
176. Crans D.C., Yang L., Alfano J.A., Chi L.-H., Jin W., Mahroof-Tahir M., Robbins K., Toloue M., Chan L.K., Plante A.J., Grayson R.Z., and Willsky G.R. Coord. Chem. Rev. 237 (2003) 13-22
177. Woo L.C.Y., Yuen V.G., Thompson K.H., McNeill J.H., and Orvig C. J. Inorg. Biochem. 76 (1999) 251-257
178. Storr T., Mitchell D., Buglyó P., Thompson K.H., Yuen V.G., McNeill J.H., and Orvig C. Bioconjug. Chem. 14 (2003) 212-221
179. Thompson K.H., Böhmerle K., Polishchuk E., Martins C., Toleikis P., Tse J., Yuen V.G., McNeill J.H., and Orvig C. J. Inorg. Biochem. 98 (2004) 2063-2070
180. Majithiya J.B., Balaraman R., Giridhar R., and Yadav M.R. J. Trace Elem. Med. Biol. 18 (2005) 211-217
181. Adachi Y., Yoshida J., Kodera Y., Katoh A., Takada J., and Sakurai H. J. Med. Chem. 49 (2006) 3251-3256
182. Joe B., Vijaykumar M., and Lokesh B.R. Crit. Rev. Food Sci. Nutr. 44 (2004) 97-111
183. Nishiyama T., Mae T., Kideyuki K., Misuzu T., Yoshihiro M., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., and Kitahara M. J. Agric. Food Chem. 53 (2005) 959-963
184. Rehder D., Costa Pessoa J., Geraldes C.F.G.C., Castro M.M.C.A., Kabanos T., Kiss T., Meier B., Micera G., Pettersson L., Rangel M., Salifoglou A., Turel I., and Wang D. J. Biol. Inorg. Chem. 7 (2002) 384-396
185. Gätjens J., Meier B., Kiss T., Nagy E.M., Buglyó P., Sakurai H., Kawabe K., and Rehder D. Chem. Eur. J. 9 (2003) 4924-4935
186. Buglyó P., Crans D.C., Nagy E.M., Lindo R.L., Yang L., Smee J.J., Jin W., Chi L.-H., Godzala III M.E., and Willsky G.R. Inorg. Chem. 44 (2005) 5416-5427
187. Delgado T.C., Tomaz A.I., Correia I., Pessoa J.C., Jones J.G., Geraldes C.F.G.C., and Castro M.M.C.A. J. Inorg. Biochem. 99 (2005) 2328-2339
188. Goldwaser I., Li J., Gershonov E., Armoni M., Karnieli E., Fridkin M., and Shechter Y. J. Biol. Chem. 274 (1999) 26617-26624
189. M. Fridkin, Y. Shechter, 2000, http://www.yedarnd.com/opportunities/. Vanadium Complexes of Monohydroxamates and Pharmaceutical Compositions Comprising Them, U.S. Patent No. 6,414,029.
190. Domingo J.L., Gomez M., Sanchez D.J., Llobet J.M., and Keen C.L. Life. Sci. 50 (1992) 1311-1317
191. Fugono J., Yasui H., and Sakurai H. J. Pharm. Pharmacol. 54 (2002) 611-615
192. Brand R.M., and Hamel F.G. Int. J. Pharm. 183 (1999) 117-123
193. Brand R.M., Duensing G., and Hamel F.G. Int. J. Pharm. 146 (1997) 115-122